These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8797582)
1. Active site-directed double mutants of dihydrofolate reductase. Ercikan-Abali EA; Mineishi S; Tong Y; Nakahara S; Waltham MC; Banerjee D; Chen W; Sadelain M; Bertino JR Cancer Res; 1996 Sep; 56(18):4142-5. PubMed ID: 8797582 [TBL] [Abstract][Full Text] [Related]
2. Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties. Ercikan-Abali EA; Waltham MC; Dicker AP; Schweitzer BI; Gritsman H; Banerjee D; Bertino JR Mol Pharmacol; 1996 Mar; 49(3):430-7. PubMed ID: 8643082 [TBL] [Abstract][Full Text] [Related]
3. Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases--inhibition by folic acid and polyphenols. Kao TT; Wang KC; Chang WN; Lin CY; Chen BH; Wu HL; Shi GY; Tsai JN; Fu TF Drug Metab Dispos; 2008 Mar; 36(3):508-16. PubMed ID: 18056255 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate resistance of mouse dihydrofolate reductase: effect of substitution of phenylalanine-31 by serine or tryptophan. Evenson DA; Adams J; McIvor RS; Wagner CR J Med Chem; 1996 Apr; 39(9):1763-6. PubMed ID: 8627598 [TBL] [Abstract][Full Text] [Related]
5. Protection of CCRF-CEM human lymphoid cells from antifolates by retroviral gene transfer of variants of murine dihydrofolate reductase. Mareya SM; Sorrentino BP; Blakley RL Cancer Gene Ther; 1998; 5(4):225-35. PubMed ID: 9694074 [TBL] [Abstract][Full Text] [Related]
6. Selectively weakened binding of methotrexate by human dihydrofolate reductase allows rapid ex vivo selection of mammalian cells. Volpato JP; Mayotte N; Fossati E; Guerrero V; Sauvageau G; Pelletier JN J Mol Recognit; 2011; 24(2):188-98. PubMed ID: 21360609 [TBL] [Abstract][Full Text] [Related]
7. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase. Volpato JP; Fossati E; Pelletier JN J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689 [TBL] [Abstract][Full Text] [Related]
9. Retroviral coexpression of thymidylate synthase and dihydrofolate reductase confers fluoropyrimidine and antifolate resistance. Fantz CR; Shaw D; Moore JG; Spencer HT Biochem Biophys Res Commun; 1998 Feb; 243(1):6-12. PubMed ID: 9473470 [TBL] [Abstract][Full Text] [Related]
10. Role of ionic interactions in ligand binding and catalysis of R67 dihydrofolate reductase. Hicks SN; Smiley RD; Hamilton JB; Howell EE Biochemistry; 2003 Sep; 42(36):10569-78. PubMed ID: 12962480 [TBL] [Abstract][Full Text] [Related]
11. Plasmodium falciparum: asparagine mutant at residue 108 of dihydrofolate reductase is an optimal antifolate-resistant single mutant. Sirawaraporn W; Yongkiettrakul S; Sirawaraporn R; Yuthavong Y; Santi DV Exp Parasitol; 1997 Nov; 87(3):245-52. PubMed ID: 9371090 [TBL] [Abstract][Full Text] [Related]
12. Defining the binding site of homotetrameric R67 dihydrofolate reductase and correlating binding enthalpy with catalysis. Strader MB; Chopra S; Jackson M; Smiley RD; Stinnett L; Wu J; Howell EE Biochemistry; 2004 Jun; 43(23):7403-12. PubMed ID: 15182183 [TBL] [Abstract][Full Text] [Related]
13. Evidence for a functional role of the dynamics of glycine-121 of Escherichia coli dihydrofolate reductase obtained from kinetic analysis of a site-directed mutant. Cameron CE; Benkovic SJ Biochemistry; 1997 Dec; 36(50):15792-800. PubMed ID: 9398309 [TBL] [Abstract][Full Text] [Related]
14. 2-tier bacterial and in vitro selection of active and methotrexate-resistant variants of human dihydrofolate reductase. Fossati E; Volpato JP; Poulin L; Guerrero V; Dugas DA; Pelletier JN J Biomol Screen; 2008 Jul; 13(6):504-14. PubMed ID: 18566481 [TBL] [Abstract][Full Text] [Related]
15. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate. James RI; May C; Vagt MD; Studebaker R; McIvor RS Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973 [TBL] [Abstract][Full Text] [Related]
17. Mutational 'hot-spots' in mammalian, bacterial and protozoal dihydrofolate reductases associated with antifolate resistance: sequence and structural comparison. Volpato JP; Pelletier JN Drug Resist Updat; 2009; 12(1-2):28-41. PubMed ID: 19272832 [TBL] [Abstract][Full Text] [Related]
18. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene. Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315 [TBL] [Abstract][Full Text] [Related]
19. Kinetic investigation of methotrexate resistant human dihydrofolate reductase (hDHFR) mutants at Phe31. Chunduru SK; Appleman JR; Blakley RL Adv Exp Med Biol; 1993; 338():507-10. PubMed ID: 8304168 [No Abstract] [Full Text] [Related]
20. Retrovirally mediated gene transfer of Arg22 and Tyr22 forms of dihydrofolate reductase into the hematopoietic cell line K562: a comparison of methotrexate resistance. Braun SE; McIvor RS; Davidson AS; Hanna M; Traycoff CM; Berebetsky DA; Gonin R; Broxmeyer HE; Cornetta K Cancer Gene Ther; 1997; 4(1):26-32. PubMed ID: 9012448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]